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Abstract : The recently developed technology of real-time cell analysis （RTCA） 
was designed to analyze cell migration and invasion in vitro.  In this study, we 
investigated these cellular factors in oral squamous cell carcinomas （OSCCs） of 
the tongue and oor of the mouth with RTCA.  We also examined the associated 
matrix metalloproteinases （MMPs） and integrins.  We used the cell lines SCC-4 
and SAS, which are human poorly differentiated OSCCs from the tongue, and HO-
1-u-1, which are human poorly differentiated OSCCs from the oor of the mouth.  
Using RTCA, cell migration was assessed on fibronectin–coated CIM-Plates, and 
invasion was assessed on bronectin- and matrigel-coated CIM-Plates.  SCC-4 cells 
demonstrated a high ability for cell migration and invasion compared with SAS and 
HO-1-u-1 cells.  The SCC-4 cells also expressed high levels of MMP-9 and integrin 
α1 mRNA compared with SAS and HO-1-u-1 cells.  The MMP inhibitor Marimas-
tat blocked migration and invasion of all OSCCs.  The ndings suggest that MMP-
9 is associated with cell migration and invasion in OSCCs, and indicate that RTCA 
will be useful for analyzing the metastatic capability of OSCCs and developing 
more effective new drugs for this disease.
Key words : oral squamous cell carcinoma, migration, invasion, matrix metalloprotein-
ase, real-time cell analyzer
Introduction
　Oral squamous cell carcinoma （OSCC） is a well-known malignancy that accounts for more 
than 90％ of all oral cancers and has a high incidence of cervical micrometastases 1, 2）.  The 
presence of lymph node metastases is one of the most important and widely accepted prognostic 
factors related to the survival of patients with OSCC 2）.  
　The metastatic cascade is a complex, multistage process involving modulation of cell phenotype, 
cell migration, and dynamic homeotypic and heterotypic cell–cell interactions 3）.  Moreover, 
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increased tumor size and microvascular invasion are the most important, independent prognostic 
factors for predicting survival in patients with OSCC 4）.  
　Matrix metalloproteinases （MMPs） are a family of zinc-dependent proteases involved in cancer 
proliferation and metastasis due to their roles in extracellular matrix （ECM） degradation, cellular 
migration, tissue remodeling, and angiogenesis 5）.  Activated MMPs degrade many ECM and 
basement membrane components 6, 7）, and as tumor cells secrete MMPs to degrade the interstitial 
matrix, microtracks of weakened and digested matrix result, enabling tumor cell migration 8）. 
In particular, MMP-2 and MMP-9 are highly expressed in OSCC compared with normal oral 
mucosa tissues, with tumor progression producing further increases at the mRNA and protein 
levels 9，10）.  In addition, MMP-2 and MMP-9 are closely associated with tumor invasion and 
metastasis in a variety of human tumors 11-13）.  
　Integrins are transmembrane heterodimeric receptors that interact with the ECM.  By 
associating laterally on the cell membrane with other proteins and by signaling to modify the 
expression of molecules such as matrix-modifying proteolytic enzymes, integrins coordinate the 
interaction of a cell with the ECM 14）.  Expression of integrins and proteases of the MMP and 
plasminogen activator families is altered in both healing and malignant epithelium, implicating 
these molecules as key factors in the process of re-epithelialization, cell migration, and tumor 
invasion 14, 15）.
　Many different experimental methods have been developed to assay tumor cell migration 
and invasion in vitro 16）, with real-time monitoring a major technical challenge.  The recently 
developed xCELLigence real-time cell analysis （RTCA ; Roche Applied Science, Mannheim, 
Germany） system has emerged as an alternative non-invasive and label-free approach that 
uses impedance detection for the continuous monitoring of cellular proliferation, migration, and 
invasion in real time on a cell culture level 17, 18）.  In this study, we applied RTCA to OSCCs of 
the tongue and floor of the mouth, and examined the associated MMPs and integrins.  
Materials and Methods  
Cell lines and reagents
　SCC-4 （JCRB9118）19） and SAS （JCRB0260）20） cells were established from a poorly 
differentiated OSCC in the tongue.  HO-1-u-1 （JCRB0828） cells were established from a poorly 
differentiated OSCC in the floor of the mouth 21）.  All cell lines were provided by the Health 
Science Research Resources Bank （Osaka, Japan）.  Marimastat, a broad-spectrum MMP inhibitor, 
was obtained from Wako Pure Chemical Industries, Ltd.  （Osaka, Japan）.
Cell culture
　SAS and HO-1-u-1 cells were cultured at 37℃ in humidified 5％ CO2 and 95％ air in 45％ 
Dulbecco’s modified Eagle’s medium, 45％ Ham’s F12 medium （DMEM/F12）, 10％ fetal bovine 
serum （FBS）, 100 U/ml penicillin, and 100μg/ml streptomycin.  The medium was changed every 
3days.  SCC-4 cells are considered undifferentiated cancer cells and were cultured in the same 
conditions in DMEM/F12 with 0.4μg/ml hydrocortisone, 10％ FBS, 100 U/ml penicillin, and 
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100μg/ml streptomycin.  The medium was changed every 3 days.
RTCA 
　We used RTCA to study migration and invasion of OSCCs 22）.  Migration was analyzed in 
a CIM-Plate 16 （Roche） coated with fibronectin （20 mg/ml）, while invasion was assessed using 
a CIM-plate 16 coated with Matrigel （1:80） （BD Biosciences, Erembodegem, Belgium） and 
fibronectin （20 mg/ml）.  For each analysis, SCC-4 cells （1.6 × 10 5）, SAS cells （3.2 × 10 5）, or 
HO-1-u-1 cells （3.2 × 10 5） were seeded in the upper chamber of a CIM-Plate 16 in 100μl 
medium for each cell line without FBS and with or without Marimastat （10 or 100μM）.  The 
upper chamber was then placed on the lower chamber of the CIM-Plate 16, which contained 
growth medium supplemented with 10％ FBS as an attractant.  
RNA isolation and quantitative real-time RT-PCR （Q-PCR）
　Q-PCR was used to quantify the mRNA levels of MMP-2 and 9 and integrin α1 and β1 in 
OSCCs.  Total RNAs were extracted with NucleoSpin RNAII （MACHEREY-NAGEL GmbH 
& Co.  KG, Duren, Germany）, and reverse transcription of total RNA was performed using 
PrimeScript RT Master Mix from TaKaRa Bio Inc.  （Shiga, Japan）.  The cDNAs were amplified 
using primers designed by ProbeFiber software （Roche）.  Table 1 details the primers used, 
the Roche Universal ProbeLibrary Probe numbers, and accession numbers.  Amplification was 
performed with a LightCycler （Roche） using LightCycler TaqMan Master mix （Roche）.  The 
PCR reaction parameters were as follows : 95℃ for 10 min, 45 cycles （except 18s, which was 
performed for 25 cycles） of 95℃ for 10s, 60℃ for 30s, and 72℃ for 1s.  Fluorescence data were 
analyzed with LightCycler software （Roche）.  The mRNA levels were compared to 18s rRNA as 
a standard, and relative expression ratios were calculated 23）.
Table 1.  Nucleotide sequences of the primers used for PCR
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Statistical analysis
　Data were analyzed with the Bonferroni test following one-way analysis of variance 
（ANOVA）.  All data were expressed as the mean ± standard error （SE） or standard deviation 
（SD）.  P values of less than 0.05 were considered significant.
Results 
　The migratory response of OSCCs was observed with RTCA on a cell culture level （Fig. 1A）. 
This response was increased early during the culture period of SCC-4 cells （approximately 12 
hours）, and we observed a high cell index level compared with SAS and HO-1-u-1 cells.  SAS 
cells showed a higher migratory response than HO-1-u-1 cells.  The invasion response was slightly 
weaker and later compared with the migratory response in OSCCs by RTCA （Fig. 1B）.  The 
order of the migratory and invasion abilities was clearly observed with RTCA as SCC-4＞ SAS 
＞HO-1-u-1.
　Figures 2 and 3 show the expression profiles of integrin and MMP mRNA, respectively.  The 
level of each mRNA in HO-1-u-1 cells was set at 100％.  Integrin α1 mRNA levels in SCC-4 
cells were 15.8 times （P＜0.01） higher than levels in HO-1-u-1 cells （Fig. 2A）, whereas integrin 
β1 （Fig. 2B） and MMP-2 （Fig. 3A） mRNA levels were not significantly different among SCC-4, 
SAS, and HO-1-u-1 cells.  MMP-9 mRNA levels in SCC-4 cells were 4.91 times （P＜0.01） and 
1.90 times （P＜0.05） higher than levels in HO-1-u-1 and SAS cells, respectively （Fig. 3B）.  
　No cell death or morphological changes were seen in OSCCs treated with 100μM Marimastat, 
an MMP inhibitor.  Lombard et al.24） also reported that human colon adenocarcinoma treated 
with 100μM Marimastat inhibited shedding of tumor necrosis factor-alpha receptors.  Therefore, 
there is little toxicity to OSCCs at concentrations less than 100μM Marimastat （data not 
shown）.  Figures 4 and 5 show that Marimastat added to the upper chamber at a concentration 
Fig. 1.  This graph shows migration （A） and invasion （B） in SCC-4, SAS, and HO-1-u-1 cell lines as indicated by the 
color code. Cells were resuspended in their respective growth media and seeded into the wells of a CIM-Plate 
16 （SCC-4 ; 1.6×10 5/well, SAS and HO-1-u-1 ; 3.2×10 5/well） of the RTCA instrument. Changes in impedance 
resulting from cells that had migrated to the bottom side of the membranes were recorded every 15 min 
and monitored for a total of 48 hours. Data are the mean values±SD of eight （SCC-4 and SAS）, four （A ; 
HO-1-u-1）, and three （B ; HO-1-u-1） wells. ＊ ; P＜0.05 vs. SAS cells, ＊＊ ; P＜0.01 vs. SAS cells, ## ; P＜0.01 vs. 
HO-1-u-1 cells.
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of 10 or 100μM significantly inhibited the migratory and invasion responses of OSCCs in a 
dose-dependent manner.  The migratory response of HO-1-u-1 cells at 48 hours in the presence 
of 100μM Marimastat was decreased by 86％ （P＜0.01 ; compared with control and 10μM 
Marimastat）, while in the presence of 10μM Marimastat, migration was reduced by 49％ （P＜
0.05 ; compared with control） after 34 hours （Fig. 4A）.  The migratory response of SAS cells in 
the presence of 100μM Marimastat was decreased by 29％ after 48 hours （P＜0.01 ; compared 
with control and 10μM Marimastat）, and by 14％ in the presence of 10μM Marimastat （P＜
0.01 ; compared with control） （Fig. 4B）.  The migratory response of SCC-4 cells was decreased 
by 44％ in the presence of 100μM Marimastat after 48 hours （P＜0.01 ; compared with 
control and 10μM Marimastat）, and by 19％ in the presence of 10μM Marimastat （P＜0.01 ; 
compared with control） （Fig. 4C）.  The invasion response of HO-1-u-1 cells in the presence 
of 100μM Marimastat was decreased by 71％ （P＜0.01 ; compared with control and 10μM 
Fig. 2.  （A） Integrin α1 and （B） Integrin β1 mRNA expression in HO-1-u-1, SAS, and SCC-4 cells relative to 
HO-1-u-1 cells as determined by quantitative real-time polymerase chain reaction are shown. Data are the 
mean±SEM. ＊＊ ; P＜0.01 vs. HO-1-u-1 cells.
Fig. 3.  （A） MMP-2 and （B） MMP-9 mRNA expression in HO-1-u-1, SAS, and SCC-4 cells relative to HO-1-u-1 
cells as determined by quantitative real-time polymerase chain reaction are shown. Data are the mean±SEM. 
＊ ; P＜0.05 vs. SAS cells, ＊＊ ; P＜0.01 vs. HO-1-u-1 cells.
Tomohiro ONO, et al208
Marimastat） after 48 hours, while invasion in the presence of 10μM Marimastat was reduced 
by 86％ （P＜0.05 ; compared with control） after 24 hours （Fig. 5A）.  The invasion response of 
SAS cells was decreased by 92％ in the presence of 100μM Marimastat （P＜0.01 ; compared 
with control and 10μM Marimastat） after 48 hours, and by 36％ in the presence of 10μM 
Marimastat （P＜0.01 ; compared with control） after the same time period （Fig. 5B）.  For SCC-
4 cells, the invasion response was decreased by 75％ in the presence of 100μM Marimastat （P
＜0.01 ; compared with control and 10μM Marimastat）, and by 24％ in the presence of 10μM 
Marimastat （P＜0.01 ; compared with control） after 48 hours （Fig. 5C）.  The invasion response 
of HO-1-u-1 cells was similar to the migratory response.  Thus, Marimastat more markedly 
decreased the invasion responses of SAS and SCC-4 cells compared with the migratory responses.
Discussion
　In this study, we demonstrated the migratory and invasion responses associated with MMP-
9 in poorly differentiated OSCCs by RTCA.  Prevention of cancer migration and invasion is an 
important strategy for improving a patient’s prognosis.  Cancer cell-matrix interaction is a critical 
step in promoting cell migration 25, 26）, and proteolytic degradation of the ECM is a critical event 
during tumor invasion and metastasis.  Cell migration across ECM tissue boundaries is required 
in many important biological processes and is dependent on the activities of proteases such as 
MMPs 27, 28）.  MMP-2 and MMP-9 are involved in metastasis 29）, making MMPs target enzymes 
for blocking migration and invasion.  Our results demonstrated that SCC-4 cells, which strongly 
express MMP-9, have high migration and invasion abilities.  This is consistent with a report by 
Lu et al. 30） that showed that downregulating MMP-9 production inhibited SCC-4 cell invasion 
and metastasis.  
　We further confirmed the association of MMPs with the invasion and metastasis abilities of 
OSSCs using Marimastat, a broad-spectrum MMP inhibitor with pharmacokinetic properties 
appropriate for chronic oral administration.  Marimastat shows potent inhibition of most of the 
major MMPs, with IC50s against MMP-2 and MMP-9 of 6 and 3 nM, respectively 31）.  Indeed, 
Peterson et al. 32） showed reduced MMP-2 and MMP-9 activities in fibrosarcoma-derived HT-1080 
cells by Marimastat.  Marimastat was shown to inhibit tumor growth in a murine model of head 
and neck squamous cell carcinoma in combination with chemoradiation 33）.  However, clinical trials 
involving Marimastat have been disappointing as many patients failed to benefit from the drug 
and also experienced significant side effects, such as musculoskeletal toxicity 34）.  In this study, 
Marimastat was effective in blocking invasion, but not as effective in blocking migration in SCC-4 
and SAS cells.  Moreover, the effect required a high concentration of Marimastat （100μM）.  
　Many cell types constitutively express MMP-2, and its promoter does not contain a TATA 
box, as is the case for many housekeeping genes35）.  Our results showed that MMP-2 mRNA 
expression was not significantly different among the OSCC cell lines studied.  On the other 
hand, MMP-9 gene transcription is inducible in most cell types 35）, and can be induced in 
specific cell types by multiple polypeptide factors, including epidermal growth factor, platelet-
derived growth factor, hepatocyte growth factor / scatter factor, basic fibroblast growth factor, 
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Fig. 4.  This graph shows the migration of HO-1-u-1 （A）, SAS （B）, and SCC-4 （C） cell lines. Cells were resuspended 
in their respective growth media and seeded into the wells of a CIM-Plate 16 （SCC-4 ; 1.6×10 5/well, SAS and 
HO-1-u-1 ; 3.2×10 5/well） of the RTCA instrument. Cells were allowed to migrate in the presence （10μM or 100μ
M, added to the upper compartment of each well） or absence of Marimastat （Marimastat （-）） as indicated by the 
color code. Changes in impedance resulting from cells that had migrated to the bottom side of the membranes were 
recorded every 15 min and monitored for a total of 48 hours. Data are the mean values±SD of wells （A ; Control, 
n＝ 6 ; 10μM, n＝ 6 ; 100μM, n＝ 4, B ; Control, n＝ 18 ; 10μM, n＝ 18 ; 100μM, n＝ 7, C ; Control, n＝ 12 ; 
10μM, n＝ 9 ; 100μM, n＝ 6）. ＊ ; P＜0.05 vs. control, ＊＊ ; P＜0.01 vs. control, # ; P＜0.05 vs. 10μM Marimastat, 
## ; P＜0.01 vs. 10μM Marimastat.
Fig. 5.  This graph shows invasion of HO-1-u-1 （A）, SAS （B）, and SCC-4 （C） cell lines. Cells were resuspended in 
their respective growth media and seeded into the wells of a CIM-Plate 16 （SCC-4 ; 1.6×105/well, SAS and 
HO-1-u-1 ; 3.2×105/well） of the RTCA instrument. Cells were allowed to migrate in the presence （10μM 
or 100μM, added to the upper compartment of each well） or absence of Marimastat （Marimastat （-）） as 
indicated by the color code. Changes in impedance resulting from cells that had migrated to the bottom side 
of the membranes were recorded every 15 min and monitored for a total of 48 hours. Data are the mean 
values±SD of wells （A ; Control, n＝ 7 ; 10μM, n＝ 4 ; 100μM, n＝ 4, B ; Control, n＝ 10 ; 10μM, n＝ 5 ; 
100μM, n＝ 10, C ; Control, n＝ 10, 10μM, n＝ 10 ; 100μM, n＝ 10）. ＊ ; P＜0.05 vs. control, ＊＊ ; P＜0.01 
vs. control, P＜0.05 vs. 10μM Marimastat, ## ; P＜0.01 vs. 10μM Marimastat.
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transforming growth factor-α, amphiregulin, tumor necrosis factor-α, interleukin-1α, interleukin-1
β, interferon-α, interferon-γ, and transforming growth factor-β, as well as by phorbol ester 
stimulation 36）.  However, poorly differentiated OSCCs, especially SCC-4 cells, may constitutively 
express MMP-9 mRNA.  MMP-9 is closely linked to the metastatic potential of tumors, and 
enhanced production of MMP-9 has been observed in highly metastatic versus minimally 
metastatic cell lines37）.
　Integrins consist of two transmembrane subunits, α and β, that form a non-covalent 
heterodimer.  Both subunits contribute to the formation of the ligand binding pocket, but the 
α subunit is likely to play an important role in determining the binding selectivity because 
heterodimers sharing a common β subunit, but with distinct α chains, often bind different 
ligands 38）.  The binding affinity state of many integrins can be regulated at the cell surface by 
several stimuli, allowing regulation of the intensity of adhesion during cellular interactions and 
migration 39）.  Several reports have shown that integrin α1β1 in particular is associated with 
migration and invasion of cancer cells 40, 41）.  In this study, SCC-4 cells in which integrin α1 
mRNA was strongly expressed showed high migration and invasion abilities.
　In summary, we used the recently developed RTCA technology to further investigate the 
migratory and invasion responses associated with MMP-9 in poorly differentiated OSCCs in 
real time.  By this strategy, we demonstrated that SCC-4 cells have high migration and invasion 
abilities, SAS cells have intermediate abilities, and HO-1-u-1 cells have low, but similar abilities in 
migration and invasion.  Therefore, RTCA will be useful for analyzing the metastatic capability 
of OSCCs, potentially leading to the development of more effective new drugs for OSCC.
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